Skip to main content
. 2025 Sep 3;42(11):5529–5546. doi: 10.1007/s12325-025-03335-z

Fig. 2.

Fig. 2

Serum concentration versus time profile for a mirikizumab 200 mg and b mirikizumab 300 mg administered subcutaneously using prefilled syringe and autoinjector. AI autoinjector, PFS prefilled syringe, SD standard deviation